Research Programme: High-throughput Screening small molecule library - Orion Pharma / Proteros biostructures
Alternative Names: HTS small molecule libraryLatest Information Update: 15 Jan 2024
At a glance
- Originator Proteros Biostructures
- Developer Orion Pharma; Proteros Biostructures
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer; Pain
Most Recent Events
- 11 Sep 2023 Early research in Pain in Germany, Finland (unspecified route)
- 07 Sep 2023 Proteros biostructures and Orion Pharma agree to collaborate and co-develop the HTS small molecule library for Cancer and Pain indications
- 06 Sep 2023 Early research in Cancer in Germany, Finland (unspecified route)